$41.05
0.74[1.84%]
At close: Apr 17
$41.05
0[0.00%]
After Hours: 4:20PM EDT
Latest News for Merus Stock (NASDAQ:MRUS)
Merus Stock (NASDAQ: MRUS)
Categories: All
Thursday, April 11, 2024
Monday, April 08, 2024
Thursday, March 28, 2024
Thursday, March 07, 2024
Tuesday, March 05, 2024
Monday, March 04, 2024
Thursday, February 29, 2024
- On Wednesday February 28, 2024, Merus Reported Q4 Adjusted. EPS $(1.09) Misses $(0.74) Estimate, Sales $8.94M Miss $10.13M EstimateHappy Mohamed - Feb 29, 2024, 3:26PM
- HC Wainwright & Co. Maintains Buy on Merus, Raises Price Target to $65Benzinga Newsdesk - Feb 29, 2024, 3:24PM
- Stifel Maintains Buy on Merus, Raises Price Target to $65Benzinga Newsdesk - Feb 29, 2024, 12:43PM
- BMO Capital Maintains Outperform on Merus, Raises Price Target to $58Benzinga Newsdesk - Feb 29, 2024, 8:08AM
Wednesday, February 28, 2024
Monday, December 04, 2023
Tuesday, November 28, 2023
Monday, November 27, 2023
Thursday, November 02, 2023
Tuesday, October 24, 2023
Monday, October 23, 2023
Friday, October 06, 2023
Thursday, September 14, 2023
Monday, September 11, 2023
Monday, August 21, 2023
Thursday, August 10, 2023
- Where Merus Stands With AnalystsBenzinga Insights - Aug 10, 2023, 12:00PM
- Citigroup Maintains Buy on Merus, Lowers Price Target to $46Benzinga Newsdesk - Aug 10, 2023, 11:56AM
- Merus Announces Pricing Of $150M Public Offering Of 6,818,182 Common Shares At $22/ShareBenzinga Newsdesk - Aug 10, 2023, 3:01AM
Wednesday, August 09, 2023
Tuesday, August 08, 2023
- Merus shares are trading lower after the company reported a year-over-year decrease in Q2 financial results.Benzinga Newsdesk - Aug 8, 2023, 1:20PM
- Guggenheim Maintains Buy on Merus, Raises Price Target to $48Benzinga Newsdesk - Aug 8, 2023, 12:51PM
- Stifel Maintains Buy on Merus, Raises Price Target to $45Benzinga Newsdesk - Aug 8, 2023, 11:04AM
- EF Hutton Reiterates Buy on Merus, Maintains $35 Price TargetBenzinga Newsdesk - Aug 8, 2023, 7:44AM
- HC Wainwright & Co. Reiterates Buy on Merus, Maintains $48 Price TargetBenzinga Newsdesk - Aug 8, 2023, 6:35AM
- Needham Reiterates Buy on Merus, Maintains $45 Price TargetBenzinga Newsdesk - Aug 8, 2023, 5:32AM
Monday, August 07, 2023
Monday, July 24, 2023
Tuesday, July 18, 2023
Wednesday, July 05, 2023
Friday, June 30, 2023
Thursday, June 29, 2023
- Merus shares are trading higher after the FDA granted Breakthrough Therapy Designation to zenocutuzumab for the treatment of NRG1+ pancreatic cancer.Benzinga Newsdesk - Jun 29, 2023, 4:32PM
- Merus Announces Zenocutuzumab Has Been Granted Breakthrough Therapy Designation By The FDA For NRG1+ Pancreatic CancerBenzinga Newsdesk - Jun 29, 2023, 4:30PM